Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups (Q41201032)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 March 2015

Language	Label	Description	Also known as
English	Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups	scientific article published on 18 March 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

World Health Organization

0 references

0 references

1 reference

based on heuristic

inferred from title

Bernhard Radlwimmer

27

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

1

object named as

Michael Weller

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

24

object named as

Wolfgang Wick

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Andreas von Deimling

30

object named as

Andreas von Deimling

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Guido Reifenberger

32

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

7

object named as

Jörg Felsberg

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Henry Löffler-Wirth

9

object named as

Henry Löffler-Wirth

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Simon Matthias May

17

object named as

Matthias Simon

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Manfred Westphal

15

object named as

Manfred Westphal

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Johannes Schramm

14

object named as

Johannes Schramm

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Gabriele Schackert

16

object named as

Gabriele Schackert

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Michael S Sabel

21

object named as

Michael Sabel

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Joachim Steinbach

11

object named as

Joachim P Steinbach

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

22

object named as

Dietmar Krex

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Dorothee Gramatzki

13

object named as

Dorothee Gramatzki

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Bettina Hentschel

5

object named as

Bettina Hentschel

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Ruthild G Weber

2

object named as

Ruthild G Weber

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Edith Willscher

3

object named as

Edith Willscher

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

4

object named as

Vera Riehmer

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Kerstin Kaulich

10

object named as

Kerstin Kaulich

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

31

object named as

Hans Binder

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Jörg-Christian Tonn

23

object named as

Jörg C Tonn

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

author name string

Markus Kreuz

6

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Ulrike Beyer

8

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Christian Hartmann

12

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Tobias Martens

18

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Jan Boström

19

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Christian Hagel

20

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Susan Noell

25

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Uwe Schlegel

26

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Torsten Pietsch

28

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Markus Loeffler

29

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Acta Neuropathologica

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

129

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

679-693

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Update on molecular findings, management and outcome in low-grade gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

alpha-Internexin expression identifies 1p19q codeleted gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

The genetic landscape of anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

The definition of primary and secondary glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Gene expression in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Molecular neuro-oncology in clinical practice: a new horizon

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Expression cartography of human tissues using self organizing maps

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Mining SOM expression portraits: feature selection and integrating concepts of molecular function

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Identifiers

10.1007/S00401-015-1409-0

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

release_4q7osaxpnvfrxke5f4gksievdy

1 reference

https://api.fatcat.wiki/v0/release/4q7osaxpnvfrxke5f4gksievdy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41201032&oldid=2204382944"